Skip to Main Content

Try STAT+ TODAY

marijuana

Most Read

Health Shafaq Zia

Cannabis use among older adults is on the rise, study says

First Opinion Shaun Khoo

Cash from cannabis companies creates conflicted researchers

First Opinion Andrea Holmes

The cannabis boom could be good for science — and scientists

First Opinion Rosalie Liccardo Pacula

States need to wake up to public health risks from cannabis

First Opinion Shari Berman

I wanted to try medical marijuana. Why couldn’t my doctors help me?

Politics Nicholas Florko

CBD is all the rage among patients. It’s launching their physicians into uncharted territory

First Opinion Julia Arnsten

Access to medical cannabis: a new health care disparity

First Opinion Lyle Hauser

Canada’s legalization of marijuana offers a blueprint for the U.S.

All Coverage

First Opinion Jordan Tishler

Cannabis legalization must address medical use, not just recreational use

First Opinion Linda Richter and Lindsey Vuolo

Lessons about marijuana edibles from youth vaping

advertisement

First Opinion Kevin Doyle

Decriminalization could help ease the nation’s drug epidemic, but the devil is in the details

Politics Nicholas Florko

The FDA is finalizing its long-awaited rules for CBD

Pharmalot Ed Silverman

DEA proposes new rule to approve new suppliers of marijuana for research

Politics Nicholas Florko

Congress asked the FDA to explain its rules on CBD — but its new report offers little clarity

Health Megan Thielking

One in five high school seniors vaped marijuana in the last year, fueling concern among health officials

Biotech Nicholas Florko

The company behind the first-ever CBD-based drug is now eyeing everything from multiple sclerosis to autism

Biotech Nicholas Florko

These four companies are betting big on CBD-based prescription drugs

Health Lev Facher

Surgeon general: Marijuana during pregnancy and adolescence is dangerous

Pharmalot Ed Silverman

Pharmalittle: Trump administration pushes for international drug pricing index; is Roche starting a price war in cancer drugs?

First Opinion Beatriz H. Carlini, Gregory Carter and Nephi Stella

Cannabidiol confusion: lofty promises and barriers to research

Health Associated Press

Marijuana use doubles in U.S. pregnant women to 1 in 14

Politics Nicholas Florko

At first-ever public hearing on CBD, advocates and FDA try to blaze trail to regulatory compromise

D.C. Diagnosis Nicholas Florko

Scott Gottlieb is skeptical of the science behind CBD supplements

Politics Nicholas Florko

Dude, where’s my regulatory framework? As CBD gains popularity, Washington struggles to keep up

Health Felice J. Freyer — Boston Globe

Harvard, MIT share $9 million gift to study marijuana’s health effects

Health Talia Bronshtein

INTERACTIVE: Explore how illegal drugs have become cheaper and more potent over time

Politics Ike Swetlitz

So your state just legalized marijuana: 6 things to know

Politics Stephanie Simon

Marijuana and soda taxes win big, but cigarette taxes fail in several state votes

Health Associated Press

Ballot could add legal marijuana to Las Vegas’s list of vices

First Opinion Kurt Isaacson

Legalizing recreational marijuana is bad for public health

Politics Leah Samuel

Hair testing for drug use gains traction — but critics say the science needs to catch up

Politics Associated Press

Pot ballot drives put medical, recreational users at odds

Politics Shayla Love

As record number of states vote on marijuana, public health questions remain